Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Initial Metabolic State People with conditions like insulin resistance, PCOS, or type 2 diabetes often take more time to see results
Retest after 46 weeks of supplementation
Contribution of five amino acid residues in the glutathione-binding site to the function of human glutathione transferase P1-1
The patients treatment phases, including pathogen elimination, detoxification, gut repair, and regeneration, aligned with the traditional 5R protocol in functional medicine, which consists of Remove, Replace, Reinoculate, Repair, and Rebalance [16]